Literature DB >> 15365411

Interpretation of liver chemistries in adult donors after living donor liver transplantation.

Mark W Russo1, Dianne LaPointe-Rudow, Alex Teixeira, James Guarrera, Lorna M Dove, Paul Gaglio, Jean C Emond, Milan Kinkhabwala, Robert S Brown.   

Abstract

OBJECTIVES: The safety of donors is paramount in adult living donor liver transplantation. Our goal is to compare the pattern of recovery of hepatic synthetic function and aminotransferases in healthy adult donors with and without complications.
METHODS: We reviewed 47 consecutive patients undergoing right donor hepatectomy at our center. Laboratory data were collected through the first 2 postoperative weeks and results from donors with and without complications were compared.
RESULTS: Donor morbidity was 25% and there were no donor deaths. Total bilirubin peaked on postoperative day 3, whereas aminotransferases and international normalized ratio peaked on postoperative day 1. Peak total bilirubin was higher in patients with fluid collections (n = 7) compared with those without fluid collections (n = 40), 4.6 mg/dL and 2.3 mg/dL, respectively, P = 0.02. On postoperative day 3 the peak total bilirubin was greater than 3.0 mg/dL in 86% of donors with fluid collections and 15% of donors without fluid collections, (P = 0.0005) whereas aminotransferases and alkaline phosphatase were not significantly different between these 2 groups.
CONCLUSIONS: After right donor hepatectomy a total bilirubin greater than 3.0 mg/dL on postoperative day 3 should prompt an evaluation for a fluid collection, even if other liver tests are normal or declining.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365411     DOI: 10.1097/01.mcg.0000139053.12920.79

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  1 in total

1.  Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study.

Authors:  James F Trotter; Brenda W Gillespie; Norah A Terrault; Michael M Abecassis; Robert M Merion; Robert S Brown; Kim M Olthoff; Paul H Hayashi; Carl L Berg; Robert A Fisher; James E Everhart
Journal:  Liver Transpl       Date:  2011-04       Impact factor: 5.799

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.